Overview

Webcast ImageWebcast
Q2 2014 Laboratory Corporation of America Holdings Earnings Conference Call (Replay)
07/18/14 at 9:00 a.m. ET
Corporate Profile

Laboratory Corporation of America® Holdings, an S&P 500 company, is a pioneer in commercializing new diagnostic technologies and the first in its industry to embrace genomic testing. With annual revenues of $5.8 billion in 2013, over 34,000 employees worldwide, and more than 220,000 clients, LabCorp offers more than 4,000 tests ranging from routine blood analyses to reproductive genetics to companion diagnostics. LabCorp furthers its scientific expertise and innovative clinical testing technolo... More >>

Recent NewsMore >>
DateTitle 
07/18/14Laboratory Corporation of America® Holdings Announces 2014 Second Quarter Results and Increases 2014 EPS Guidance
Sales of $1.52 billion Diluted EPS of $1.64; Adjusted EPS of $1.84 Operating Cash Flow of $207 million; Free Cash Flow of $159 million 2014 Adjusted EPS guidance raised to $6.50 - $6.75 BURLINGTON, N.C.--(BUSINESS WIRE)--Jul. 18, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced results for the quarter ended June 30, 2014. Second Quarte... 
Printer Friendly Version
07/01/14Conversion Right Triggered for LabCorp’s Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.--(BUSINESS WIRE)--Jul. 1, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today that its Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be converted as set forth below. The Zero Coupon Notes are convertible into cash and Common Stock of LabCorp, if any, subject to the terms of the Zero Coupon Notes and the Indenture, dated as of October 24, 2006 between LabCorp and T... 
Printer Friendly Version
05/19/14LabCorp Announces the Availability of Luminex xTAG® CYP2D6 Genotype Assay
BURLINGTON, N.C.--(BUSINESS WIRE)--May 19, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced today the availability of the xTAG® CYP2D6 Kit v3 from Luminex Corporation (NASDAQ: LMNX). The xTAG CYP2D6 Kit v3 is an FDA cleared qualitative genotyping assay that aids clinicians in determining strategies for therapeutics metabolized by the CYP2D6 gene product. CYP2D6 is one of the genes in the cytochrome P450 fa... 
Printer Friendly Version
05/08/14LabCorp is Scheduled to Present at the Bank of America Merrill Lynch 2014 Health Care Conference
BURLINGTON, N.C.--(BUSINESS WIRE)--May 8, 2014-- Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Bank of America Merrill Lynch 2014 Health Care Conference in Las Vegas, NV. LabCorp’s presentation is planned for Thursday, May 15, 2014 at 9:20 a.m. (PT). About LabCorp® Laboratory Corporation of America® Holdings, a... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
LH (Common)
ExchangeNYSE
Price$105.63
Change Stock is Up 0.03
Intraday High$105.75
Intraday Low$104.64
Volume499,082
Data as of 07/23/14
4:01 p.m. ET
Minimum 20 minute delay
Refresh quote

Reports & Performance

2013 Annual Report

2012 Annual Report

2011 Annual Report

2010 Annual Report

2009 Annual Report

2008 Annual Report

2007 Annual Report

2006 Annual Report

Latest Earnings Release